BiologicsMD Signs Deal to Make Its Osteoporosis Treatment

by Mark Carter  on Tuesday, Jun. 12, 2012 10:37 am   2 min read

BioMD President Paul Mlakar, left, with Ensysce Biosciences CEO Lynn Kirkpatrick.

BiologicsMD of Fayetteville has contracted for the manufacture of its osteoporosis treatment and welcomed a new board member to help guide it through the FDA approval process.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.